Research and Clinical Trials
Each year, numerous BIDMC research faculty in the Liver Tumor Group are:
- Published in prestigious scientific and medical journals
- Awarded prominent and highly competitive research grants
- Recognized for far-ranging scientific achievement
- Engaged in clinical trials, to bring research from the laboratory bench to the patient bedside
Physician researchers and scientists are working to perfect targeted or personalized cancer therapy designed to attack the genetic structure of an individual tumor.
Liver Center and Transplant Institute physicians and staff also are recognized nationally as leaders in cutting-edge, liver-related basic and clinical (laboratory and patient-related) research. Additionally, the center’s core concept integrates patient care with advanced research for state-of-the-art treatment and therapy. Our dedicated Liver Research Program, the first of its kind in New England, enrolls hundreds of patients annually in clinical trials.
Researchers at BIDMC recently led a study that may help point to earlier diagnostic methods – and subsequent treatments – for liver cancer. Click here to read a summary of the findings.
S. Nahum Goldberg, MD, Associate Professor in Radiology at Harvard Medical School and Staff Radiologist at BIDMC, directs the Abdominal Intervention and Tumor Ablation Therapy Program and Minimally Invasive Tumor Therapy Laboratory. His research focuses on the development of image-guided, minimally invasive oncologic therapies such as radiofrequency ablation, used in combination with biologic modulators, chemotherapy and radiation, to treat liver and other cancers.
Rebecca A. Miksad, MD, MPH, Instructor in Medicine and an oncologist specializing in liver tumors, co-directed the First Annual Harvard Hepatocellular Cancer Research Conference, which featured 12 research presentations, several from BIDMC faculty members, and was attended by more than 50 participants. In addition to Dr. Miksad, BIDMC faculty presenters included Elizabeth I. Buchbinder, MD; Daniel C. Cho, MD; Kun Ping Lu, MD, PhD; James W. Mier, MD; and Xiao Zhen Zhou, MD. Click on their names for more information about their research focus.
Physicians are also working to build a comprehensive liver cancer outcomes research database to continue to identify best strategies for treatment.
For more information on gastrointestinal cancer research programs, please click here.
For more information on liver research in the Transplant Institute, please click here.
